Both in Pharmaceuticals
RenovoRx vs Xilio Therapeutics
Over the past year RNXT returned +9.3% and XLO returned −31.6%; their daily moves had a correlation of -0.08.
RNXT +9.3% XLO −31.6%Growth of $1, one year, split-adjusted
| Metric | RNXT | XLO |
|---|---|---|
| Price | $1.29 | $7.57 |
| Market cap | $58.2M | $49.8M |
| Today | +1.57% | −5.73% |
| 1 month | −23.2% | −15.9% |
| 6 months | +50.6% | −8.9% |
| Year to date | +53.6% | −15.5% |
| 1 year | +14.2% | −28.2% |
| Revenue growth (YoY) | +115.4% | +131.2% |
| Gross margin | 84.3% | 100.0% |
| Net margin | −320.2% | −34.1% |
| P/E (TTM) | — | — |
| Price / sales | 29.5× | 0.8× |
| Net cash | $9.5M | $136.0M |
| Dividend yield | — | — |
| Volatility (60d) | 107.5% | 26.3% |
| Short % of float | 2.2% | 10.3% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).